Consolidated revenue for Q1 FY2027 reached 90,105 million yen (YoY +4.5%), operating income 18,077 million yen (\u25b38.6%), and net income attributable to owners of parent 10,579 million yen (\u25b321.8%). Segment-wise, Medical Platform and International segments were solid, but profitability worsened notably in Site Solutions. Full-year guidance is currently undetermined.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2413","jir_company_name":"M3, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/2413-20260806-01.pdf","jir_short_summary":"Consolidated revenue for Q1 FY2027 reached 90,105 million yen (YoY +4.5%), operating income 18,077 million yen (\u25b38.6%), and net income attributable to owners of parent 10,579 million yen (\u25b321.8%). Segment-wise, Medical Platform and International segments were solid, but profitability worsened notably in Site Solutions. Full-year guidance is currently undetermined.","jir_summary":"### Performance overview\nConsolidated revenue for the quarter increased 4.5% year over year to 90,105 million yen. Operating income declined 8.6% year over year to 18,077 million yen, and pre-tax income fell 5.3% year over year to 18,641 million yen, with net income decreasing 21.8% year over year to 10,579 million yen. By segment, Medical Platform and International were solid, while profitability deteriorated notably in Site Solutions. The impact of new subsidiaries and ongoing pre-investments likely weighed on profits.\n\n### Outlook and dividends\nFull-year earnings guidance remains undetermined per the disclosed assumptions. The company plans to determine the dividend level taking into account capital needs and cash flow conditions. An accompanying earnings presentation is expected to be released, with further details on management performance to be disclosed in due course.","jir_financial_highlights":"Revenue: 90,105 (YoY +4.5%)\nOperating income: 18,077 (YoY \u25b38.6% decrease)\nProfit before tax (quarterly): 18,641 (YoY \u25b35.3% decrease)\nNet income for the quarter: 10,579 (YoY \u25b321.8% decrease)\nTotal assets: 634,803 (YoY \u25b32,592)\nNumber of treasury shares: 11,695,139 shares (Same as prior year-end)","jir_category":"","jir_hashtags":"#M3, #FinancialResults, #EarningsTrend","jir_key_figures":"Revenue: 90,105 million yen (YoY +4.5%)\nOperating income: 18,077 million yen (YoY -8.6%)\nNet income: 10,579 million yen (YoY -21.8%)","jir_meta_title":"M3 Q1 FY2027 Earnings Release | Revenue 90,105 million yen, Profitability Mixed","jir_meta_description":"Summary of M3's Q1 FY2027 results. Revenue rose 4.5% year over year to 90,105 million yen; operating income declined 8.6%; net income declined 21.8%. Discussion of segment trends and undetermined full-year guidance.","jir_og_title":"M3 Q1 Earnings Preview: Revenue 90,105 million yen, Profitability Struggles","jir_og_description":"Summary of M3's Q1 FY2027 earnings. Revenue increased, but profits declined. Outline of segment performance and outlook.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7464,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-97400","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n